Skip to main content Accessibility help
×
Home

The Epileptic Encephalopathies of Infancy and Childhood

  • Elaine Wirrell (a1), Kevin Farrell (a2) and Sharon Whiting (a3)

Abstract:

The epileptic encephalopathies comprise a group of devastating seizure syndromes which begin in infancy and early childhood and usually result in intractable epilepsy. While some syndromes are relatively easily diagnosed early in their course, others take time to evolve, hampering an early, confident diagnosis. Epileptic encephalopathies are associated with slowing of cognitive function and evolution of severe behavioral disorders, which are often more distressing to families than the epilepsy. While an underlying etiology may explain some of this co-morbidity, many children have no identifiable etiology found for their seizures. In these “idiopathic” cases, recurrent subtle seizures, frequent epileptiform discharge and non-convulsive status epilepticus probably all play a role in deterioration of cognitive function and evolution of behavior disorders. This paper will review the most common epileptic encephalopathy syndromes, discuss the cognitive and behavioral co-morbidities and review current therapeutic options.

RÉSUMÉ:

Les encéphalopathies épileptiques incluent un groupe de syndromes épileptiques dévastateurs qui commencent dans la petite enfance et qui causent une épilepsie réfractaire au traitement. Bien que certains syndromes soient relativement faciles à diagnostiquer tôt au cours de la maladie, d’autres évoluent plus lentement ce qui retarde souvent le moment où un diagnostic ferme est posé. Les encéphalopathies épileptiques sont associées à un ralentissement des fonctions cognitives et au développement de troubles comportementaux sévères qui causent souvent plus de désarroi dans la famille que l’épilepsie. Bien qu’une pathologie sous-jacente peut expliquer en partie cette co-morbidité, on n’identifie chez plusieurs enfants aucune étiologie expliquant leurs crises. Chez ces cas « idiopathiques », des crises subtiles récurrentes, des décharges épileptiformes fréquentes et un état de mal épileptique non convulsif jouent probablement un rôle dans la détérioration de la fonction cognitive et l’évolution des troubles du comportement. Cet article revoit les syndromes encépahlopathiques épileptiques, discute les comorbidités cognitives et comportementales et revoit les options thérapeutiques actuelles.

    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      The Epileptic Encephalopathies of Infancy and Childhood
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      The Epileptic Encephalopathies of Infancy and Childhood
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      The Epileptic Encephalopathies of Infancy and Childhood
      Available formats
      ×

Copyright

Corresponding author

Division of Pediatric Neurology, Alberta Children’s Hospital, 1820 Richmond Rd SW, Calgary, AB Canada T2T 5C7

References

Hide All
1. Commission on Classification and Terminology of the InternationalLeague Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:389399.
2. Aicardi, J. Early myoclonic encephalopathy. In Roger, J, Bureau, M, Dravet, C, Dreifuss, FE, Perret, A, Wolf, P, (Eds). Epileptic Syndromes in Infancy, Childhood and Adolescence, 2 ed. London John Libbey and Company, 1992:1323.
3. Ohtahara, S, Ohtsuka, O, Yamatogi, Y, Oka, E, Inoue, H. Early-infantileepileptic encephalopathy with suppression bursts. In Roger, J, Bureau, M, Dravet, C, Dreifuss, FE, Perret, A, Wolf, P, (Eds). Epileptic Syndromes in Infancy, Childhood and Adolescence, 2 ed. London John Libbey and Company, 1992:2534.
4. Oka, E, Ohno, M, Minakuchi, E, Ohtahara, S. Indication of surgery forchildhood epilepsy. Jpn J Psychiatry Neurol 1992;46:345349.
5. Coppola, G, Plouin, P, Chiron, C, Robain, O, Dulac, O. Migratingpartial seizures in infancy a malignant disorder with developmental arrest. Epilepsia 1995;36:10171024.
6. Dulac, O. Epileptic encephalopathy. Epilepsia 2001;42 Suppl 3:2326.
7. Jeavons, PM, Livet, MO. West syndrome infantile spasms. In Roger, J, Bureau, M, Dravet, C, Dreifuss, FE, Perret, A, Wolf, P, (Eds). Epileptic Syndromes in Infancy, Childhood and Adolescence, 2 ed. London John Libbey and Company, 1992:5365.
8. Lux, AL, Osborne, JP. A proposal for case definitions and outcomemeasures in studies of infantile spasms and West syndrome consensus statement of the West Delphi group. Epilepsia 2004;45:14161428.
9. Hrachovy, RA, Frost, JD Jr., Kellaway, P. Hypsarrhythmia variationson the theme. Epilepsia 1984;25:317325.
10. Dravet, C, Bureau, M Guerrini, R, Giraud, N, Roger, J. Severemyoclonic epilepsy in infancy. In Roger, J, Bureau, M, Dravet, C, Dreifuss, FE, Perret, A, Wolf, P, (Eds). Epileptic Syndromes in Infancy, Childhood and Adolescence, 2 ed. London John Libbeyand Company, 1992:7588.
11. Kanai, K, Hirose, S, Oguni, H, et al. Effect of localization of missensemutations in SCN1A on epilepsy phenotype severity. Neurology 2004;63:329334.
12. Beaumanoir, A DC. The Lennox-Gastaut syndrome. In Roger, J, Bureau, M, Dravet, C, Dreifuss, FE, Perret, A, Wolf, P, (Eds). Epileptic Syndromes in Infancy, Childhood and Adolescence, 2 ed. London John Libbey and Company, 1992:115132.
13. Goldsmith, IL, Zupanc, ML, Buchhalter, JR. Long-term seizureoutcome in 74 patients with Lennox-Gastaut syndrome effects of incorporating MRI head imaging in defining the cryptogenic subgroup. Epilepsia 2000;41:395399.
14. Dulac, O, N'Guyen, T. The Lennox-Gastaut syndrome. Epilepsia 1993;34 Suppl 7:S7-17.
15. Markand, ON. Lennox-Gastaut syndrome (childhood epilepticencephalopathy). J Clin Neurophysiol 2003;20:426441.
16. Boniver, C, Dravet, C, Bureau, M, Roger, J. Idiopathic Lennox-Gastaut syndrome. Advances in Epileptology 1987;16:195200.
17. Oguni, H, Hayashi, K, Osawa, M. Long-term prognosis of Lennox-Gastaut syndrome. Epilepsia 1996;37 Suppl 3:4447.
18. Doose, H. Myoclonic astatic epilepsy of early childhood. In Roger, J, Bureau, M, Dravet, C, Dreifuss, FE, Perret, A, Wolf, P, (Eds). Epileptic Syndromes of Infancy, Childhood and Adolescence, 2 ed. London John Libbey and Company, 1992:103114.
19. Scheffer, IE, Wallace, R, Mulley, JC, Berkovic, SF. Clinical andmolecular genetics of myoclonic-astatic epilepsy and severe myoclonic epilepsy in infancy (Dravet syndrome). Brain Dev 2001;23:732735.
20. Aicardi, J. Myoclonic-astatic epilepsy. In Wallace, SJ, Farrell, K, (Eds). Epilepsy in Children. London Arnold, 2004;163168.
21. Hahn, A, Pistohl, J, Neubauer, BA, Stephani, U. Atypical “benign” partial epilepsy or pseudo-Lennox syndrome. Part I symptomatology and long-term prognosis. Neuropediatrics 2001;32:18.
22. Beaumanoir, A. The Landau-Kleffner syndrome. In Roger, J, Bureau, M, Dravet, C, Dreifuss, FE, Perret, A, Wolf, P, (Eds). Epileptic Syndromes in Infancy, Childhood and Adolescence, 2 ed. London John Libbey and Company, 1992:231243.
23. Tassinari, CA, Bureau, M, Dravet, C, Dalla Bernardina, B, Roger, J. Epilepsy with continuous spikes and waves during slow sleep -otherwise described as ESES (epilepsy with electrical status epilepticus during slow sleep). In Roger, J, Bureau, M, Dravet, C, Dreifuss, FE, Perret, A, Wolf, P, (Eds). Epileptic Syndromes in Infancy, Childhood and Adolescence, 2 ed. London John Libbeyand Company, 1992:245256.
24. Jambaque, I. Neuropsychological Aspects. In Dulac, O, Chugani, HT, Dalla Bernardina, B, (Eds). Infantile Spasms and West Syndrome, 1 ed. London WB Saunders, 1994:8287.
25. Kivity, S, Lerman, P, Ariel, R, et al. Long-term cognitive outcomesof a cohort of children with cryptogenic infantile spasms treated with high-dose adrenocorticotropic hormone. Epilepsia 2004;45:255262.
26. Riikonen, R, Amnell, G. Psychiatric disorders in children with earlierinfantile spasms. Dev Med Child Neurol 1981;23:747760.
27. Askalan, R, Mackay, M, Brian, J, et al. Prospective preliminaryanalysis of the development of autism and epilepsy in children with infantile spasms. J Child Neurol 2003;18:165170.
28. Hunt, A, Dennis, J. Psychiatric disorder among children withtuberous sclerosis. Dev Med Child Neurol 1987;29:190198.
29. Bolton, PF. Neuroepileptic correlates of autistic symptomatology intuberous sclerosis. Ment Retard Dev Disabil Res Rev 2004;10:126131.
30. Casse-Perrot, C, Wolf, M, Dravet, C. Neuropsychological aspects ofsevere myoclonic epilepsy in infancy. In Jambaque, I, Lassonde, M, Dulac, O, (Eds). Neuropsychology of Childhood Epilepsy, 1 ed. New York Kluwer Academic/Plenum Publishers, 2005:131140.
31. Boel, MJ. Behavioural and neuropsychological problems inrefractory paediatric epilepsies. Eur J Paediatr Neurol 2004;8:291297.
32. Kieffer-Renaux, V, Kaminska, A, Dulac, O. Cognitive deterioration inLennox-Gastaut syndrome and Doose epilepsy. In Jambaque, I, Lassonde, M, Dulac, O, (Eds). Neuropsychology of Childhood Epilepsy, 1 ed. New York Kluwer Academic/Plenum, 2001:185190.
33. Blume, WT, David, RB, Gomez, MR. Generalized sharp and slowwave complexes associated clinical features and long-termfollow-up. Brain 1973;96:289306.
34. Loring, DW, Meador, KJ. Cognitive side effects of antiepilepticdrugs in children. Neurology 2004;62:872877.
35. Camfield, CS, Chaplin, S, Doyle, AB, et al. Side effects ofphenobarbital in toddlers; behavioral and cognitive aspects. J Pediatr 1979;95:361365.
36. Hellstrom, B, Barlach-Christoffersen, M. Influence of phenobarbitalon the psychomotor development and behaviour in preschool children with convulsions. Neuropadiatrie 1980;11:151160.
37. Farwell, JR, Lee, YJ, Hirtz, DG, Sulzbacher, SI, Ellenberg, JH, Nelson, KB. Phenobarbital for febrile seizures--effects on intelligence and on seizure recurrence. N Engl J Med 1990;322:364369.
38. Stores, G, Williams, PL, Styles, E, Zaiwalla, Z. Psychological effectsof sodium valproate and carbamazepine in epilepsy. Arch Dis Child 1992;67:13301337.
39. Forsythe, I, Butler, R, Berg, I, McGuire, R. Cognitive impairment innew cases of epilepsy randomly assigned to carbamazepine, phenytoin and sodium valproate. Dev Med Child Neurol 1991;33:524534.
40. Gallassi, R, Morreale, A, Di, SR, et al. Cognitive effects ofantiepileptic drug discontinuation. Epilepsia 1992;33 Suppl 6:S41-S44.
41. Aldenkamp, AP, Alpherts, WC, Blennow, G, et al. Withdrawal ofantiepileptic medication in children--effects on cognitive function The Multicenter Holmfrid Study. Neurology 1993;43:4150.
42. Elterman, RD, Glauser, TA, Wyllie, E, et al. A double-blind,randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children. Topiramate YP Study Group. Neurology 1999;52:13381344.
43. Aldenkamp, AP, Arends, J. Effects of epileptiform EEG dischargeson cognitive function is the concept of “transient cognitive impairment” still valid? Epilepsy Behav 2004;5 Suppl 1:S25-S34.
44. Kasteleijn-Nolst Trenite, DG. Transient cognitive impairment duringsubclinical epileptiform electroencephalographic discharges. Semin Pediatr Neurol 1995;2:246253.
45. Stores, G, Zaiwalla, Z, Styles, E, Hoshika, A. Non-convulsive statusepilepticus. Arch Dis Child 1995;73:106111.
46. Manning, DJ, Rosenbloom, L. Non-convulsive status epilepticus. Arch Dis Child 1987;62:3740.
47. Hoffmann-Riem, M, Diener, W, Benninger, C, et al. Nonconvulsivestatus epilepticus-- a possible cause of mental retardation in patients with Lennox-Gastaut syndrome. Neuropediatrics 2000;31:169174.
48. Tassinari, CA, Daniele, O, Michelucci, R, et al. Benzodiazepines: efficacy in status epilepticus. Adv Neurol 1983;34:465475.
49. Livingston, JH, Brown, JK. Non-convulsive status epilepticusresistant to benzodiazepines. Arch Dis Child 1987;62:4144.
50. Tassinari, CA, Dravet, C, Roger, J, Cano, JP, Gastaut, H. Tonic statusepilepticus precipitated by intravenous benzodiazepine in five patients with Lennox-Gastaut syndrome. Epilepsia 1972;13:421435.
51. Shields, WD, Saslow, E. Myoclonic, atonic, and absence seizuresfollowing institution of carbamazepine therapy in children. Neurology 1983;33:14871489.
52. Lerman, P. Seizures induced or aggravated by anticonvulsants. Epilepsia 1986;27:706710.
53. Snead, OC III, Hosey, LC. Exacerbation of seizures in children bycarbamazepine. N Engl J Med 1985;313:916921.
54. Osorio, I, Reed, RC, Peltzer, JN. Refractory idiopathic absence statusepilepticus A probable paradoxical effect of phenytoin andcarbamazepine. Epilepsia 2000;41:887894.
55. Viani, F, Romeo, A, Viri, M, et al. Seizure and EEG patterns inAngelman's syndrome. J Child Neurol 1995;10:467471.
56. Corda, D, Gelisse, P, Genton, P, Dravet, C, Baldy-Moulinier, M. Incidence of drug-induced aggravation in benign epilepsy with centrotemporal spikes. Epilepsia 200;42:754759.
57. Eldridge, R, Iivanainen, M, Stern, R, Koerber, T, Wilder, BJ. “Baltic” myoclonus epilepsy hereditary disorder of childhood made worse by phenytoin. Lancet 1983;2:838842.
58. Guerrini, R, Dravet, C, Genton, P, et al. Lamotrigine and seizureaggravation in severe myoclonic epilepsy. Epilepsia 1998;39:508512.
59. Ettinger, AB, Bernal, OG, Andriola, MR, et al. Two cases ofnonconvulsive status epilepticus in association with tiagabine therapy. Epilepsia 1999;40:11591162.
60. Vossler, DG. Exacerbation of seizures in Lennox-Gastaut syndromeby gabapentin. Neurology 1996;46:852853.
61. Hancock, E, Osborne, JP. Vigabatrin in the treatment of infantilespasms in tuberous sclerosis literature review. J Child Neurol 1999;14:7174.
62. Jambaque, I, Chiron, C, Dumas, C, Mumford, J, Dulac, O. Mental andbehavioural outcome of infantile epilepsy treated by vigabatrin in tuberous sclerosis patients. Epilepsy Res 2000;38:151160.
63. Chiron, C, Marchand, MC, Tran, A, et al. Stiripentol in severemyoclonic epilepsy in infancy a randomised placebo-controlled syndrome-dedicated trial. STICLO study group. Lancet 2000;356:16381642.
64. Coppola, G, Capovilla, G, Montagnini, A, et al. Topiramate as add-ondrug in severe myoclonic epilepsy in infancy an Italian multicenter open trial. Epilepsy Res 2002;49:4548.
65. Brown, P, Steiger, MJ, Thompson, PD, et al. Effectiveness ofpiracetam in cortical myoclonus. Mov Disord 1993;8:6368.
66. Genton, P, Guerrini, R, Remy, C. Piracetam in the treatment ofcortical myoclonus. Pharmacopsychiatry 1999;32 Suppl 1:4953.
67. Ikeda, A, Shibasaki, H, Tashiro, K, Mizuno, Y, Kimura, J. Clinical trialof piracetam in patients with myoclonus nationwide multiinstitution study in Japan. The Myoclonus/Piracetam StudyGroup. Mov Disord 1996 Nov;11(6):691700.
68. Guerrini, R, De Lorey, TM, Bonanni, P, et al. Cortical myoclonus inAngelman syndrome. Ann Neurol 1996 Jul;40(1):3948.
69. Conry, JA Sea, R. Efficacy of zonisamide in progressive myoclonicepilepsy a case series. Ann Neurol 2001;50 (suppl 3):S104Abs.
70. Kyllerman, M, Ben-Menachem, E. Zonisamide for progressivemyoclonus epilepsy long-term observations in seven patients. Epilepsy Res 1998;29:109114.
71. Rating, D, Wolf, C, Bast, T. Sulthiame as monotherapy in childrenwith benign childhood epilepsy with centrotemporal spikes a 6-month randomized, double-blind, placebo-controlled study.Sulthiame Study Group. Epilepsia 2000;41:12841288.
72. Baxter, P, Griffiths, P, Kelly, T, Gardner-Medwin, D. Pyridoxine-dependent seizures demographic, clinical, MRI and psychometric features, and effect of dose on intelligence quotient. Dev Med Child Neurol 1996;38:9981006.
73. Torres, OA, Miller, VS, Buist, NM, Hyland, K. Folinic acid-responsive neonatal seizures. J Child Neurol 1999;14:529532.
74. Wolf, B, Heard, GS, Weissbecker, KA, et al. Biotinidase deficiency: initial clinical features and rapid diagnosis. Ann Neurol 1985;18:614617.
75. Eriksson, AS, Nergardh, A, Hoppu, K. The efficacy of lamotrigine inchildren and adolescents with refractory generalized epilepsy a randomized,double-blind,crossoverstudy. Epilepsia 1998;39:495501.
76. Sachdeo, RC, Glauser, TA, Ritter, F, et al. A double-blind, randomizedtrial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study Group. Neurology 1999;52:18821887.
77. Coppola, G, Caliendo, G, Veggiotti, P, et al. Topiramate as add-ondrug in children, adolescents and young adults with Lennox-Gastaut syndrome an Italian multicentric study. Epilepsy Res 2002;51:147153.
78. Motte, J, Trevathan, E, Arvidsson, JF, et al. Lamotrigine forgeneralized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group. N Engl J Med 1997;337:18071812.
79. Efficacy of felbamate in childhood epileptic encephalopathy(Lennox-Gastaut syndrome). The Felbamate Study Group inLennox-Gastaut Syndrome. N Engl J Med 1993;328:2933.
80. Hancock, E, Cross, H. Treatment of Lennox-Gastaut syndrome. Cochrane Database Syst Rev 2003;(3):CD003277.
81. Mackay, MT, Weiss, SK, ms-Webber, T, et al. Practice parameter: medical treatment of infantile spasms report of the American Academy of Neurology and the Child Neurology Society. Neurology 2004 May 25;62(10):16681681.
82. Hrachovy, RA, Frost, JD Jr., Kellaway, P, Zion, TE. Double-blindstudy of ACTH vs prednisone therapy in infantile spasms. J Pediatr 1983;103:641645.
83. Baram, TZ, Mitchell, WG, Tournay, A, et al. High-dose corticotropin(ACTH) versus prednisone for infantile spasms a prospective, randomized, blinded study. Pediatrics 1996;97:375379.
84. Snead, OC III, Benton, JW, Myers, GJ. ACTH and prednisone inchildhood seizure disorders. Neurology 1983;33:966970.
85. Hrachovy, RA, Frost, JD Jr., Glaze, DG. High-dose, long-durationversus low-dose, short-duration corticotropin therapy for infantile spasms. J Pediatr 1994;124(5 Pt 1):803806.
86. Yanagaki, S, Oguni, H, Hayashi, K, et al. A comparative study ofhigh-dose and low-dose ACTH therapy for West syndrome. Brain Dev 1999;21:461467.
87. Lombroso, CT. A prospective study of infantile spasms clinical andtherapeutic correlations. Epilepsia 1983;24:135158.
88. Marescaux, C, Hirsch, E, Finck, S, et al. Landau-Kleffner syndrome: a pharmacologic study of five cases. Epilepsia 1990;31:768777.
89. Lerman, P, Lerman-Sagie, T, Kivity, S. Effect of early corticosteroidtherapy for Landau-Kleffner syndrome. Dev Med Child Neurol 1991;33:257260.
90. Tsuru, T, Mori, M, Mizuguchi, M, Momoi, MY. Effects of high-doseintravenous corticosteroid therapy in Landau-Kleffner syndrome. Pediatr Neurol 2000;22:145147.
91. Yamatogi, Y, Ohtsuka, Y, Ishida, T, et al. Treatment of the Lennoxsyndrome with ACTH a clinical and electroencephalographic study. Brain Dev 1979;1:267276.
92. van Rijckevorsel-Harmant, K, Delire, M, Schmitz-Moorman, W, Wieser, HG. Treatment of refractory epilepsy with intravenous immunoglobulins. Results of the first double-blind/dose finding clinical study. Int J Clin Lab Res 1994;24:162166.
93. Illum, N, Taudorf, K, Heilmann, C, et al. Intravenousimmunoglobulin a single-blind trial in children with Lennox-Gastaut syndrome. Neuropediatrics 1990;21:8790.
94. Freeman, JM, Vining, EP, Pillas, DJ, et al. The efficacy of theketogenic diet-1998 a prospective evaluation of intervention in 150 children. Pediatrics 1998;102:13581363.
95. Vining, EP, Freeman, JM, Ballaban-Gil, K, et al. A multicenter studyof the efficacy of the ketogenic diet. Arch Neurol 1998;55:14331437.
96. Lefevre, F, Aronson, N. Ketogenic diet for the treatment of refractoryepilepsy in children A systematic review of efficacy. Pediatrics 2000;105:E46.
97. Nordli, DR Jr., Kuroda, MM, Carroll, J, et al. Experience with theketogenic diet in infants. Pediatrics 2001;108:129133.
98. Kossoff, EH, Pyzik, PL, McGrogan, JR, Vining, EP, Freeman, JM. Efficacy of the ketogenic diet for infantile spasms. Pediatrics 2002;109:780783.
99. Oguni, H, Tanaka, T, Hayashi, K, et al. Treatment and long-termprognosis of myoclonic-astatic epilepsy of early childhood. Neuropediatrics 2002;33:122132.
100. Fejerman, N, Caraballo, R, Cersosimo, R. Ketogenic diet in patientswith Dravet syndrome and myoclonic epilepsies in infancy andearly childhood. Adv Neurol 2005;95:299305.
101. Moreno Villares, JM, Oliveros-Leal, L, Simon-Heras, R, Mateos-Beato, F. [The return to the ketogenic diet. What role does it play in the treatment of refractory seizures of infancy?]. Rev Neurol 2001;32:11151119.
102. Pulsifer, MB, Gordon, JM, Brandt, J, Vining, EP, Freeman, JM. Effectsof ketogenic diet on development and behavior preliminary report of a prospective study. Dev Med Child Neurol 2001;43:301306.
103. Chugani, HT, Shewmon, DA, Shields, WD, et al. Surgery forintractableinfantile spasms neuroimaging perspectives. Epilepsia 1993;34:764771.
104. Asarnow, RF, LoPresti, C, Guthrie, D, et al. Developmental outcomesin children receiving resection surgery for medically intractableinfantile spasms. Dev Med Child Neurol 1997;39:430440.
105. Chugani, DC, Chugani, HT, Muzik, O, et al. Imaging epileptogenictubers in children with tuberous sclerosis complex using alpha-[11C]methyl-L-tryptophan positron emission tomography. AnnNeurol 1998;44:858866.
106. Quarato, PP, Gennaro, GD, Manfredi, M, Esposito, V. AtypicalLennox-Gastaut syndrome successfully treated with removal of a parietal dysembryoplastic tumour. Seizure 2002;11:325329.
107. Morrell, F, Whisler, WW, Smith, MC, et al. Landau-Kleffnersyndrome. Treatment with subpial intracortical transection. Brain 1995;118:15291546.
108. Buelow, JM, Aydelott, P, Pierz, DM, Heck, B. Multiple subpialtransection for Landau-Kleffner syndrome. AORN J 1996;63:727735, 737.
109. Irwin, K, Birch, V, Lees, J, et al. Multiple subpial transection in Landau-Kleffner syndrome. Dev Med Child Neurol 2001;43:248252.
110. Grote, CL, Van, SP, Hoeppner, JA. Language outcome followingmultiple subpial transection for Landau-Kleffner syndrome. Brain 1999;122:561566.
111. Cendes, F, Ragazzo, PC, da, C V, Martins, LF. Corpus callosotomy intreatment of medically resistant epilepsy preliminary results in a pediatric population. Epilepsia 1993;34:910917.
112. McInerney, J, Siegel, AM, Nordgren, RE, et al. Long-term seizureoutcome following corpus callosotomy in children. StereotactFunct Neurosurg 1999;73:7983.
113. Parker, AP, Polkey, CE, Binnie, CD, et al. Vagal nerve stimulation inepileptic encephalopathies. Pediatrics 1999;103:778782.
114. Aldenkamp, AP, Majoie, HJM, Berfelo, MW, et al. Long-term effectsof 24-month treatment with vagus nerve stimulation on behaviour in children with Lennox-Gastaut syndrome. Epilepsy Behav 2002;3:475479Abs.
115. Frost, M, Gates, J, Helmers, SL, et al. Vagus nerve stimulation inchildren with refractory seizures associated with Lennox-Gastaut syndrome. Epilepsia 2001;42:11481152.
116. Hosain, S, Nikalov, B, Harden, C, Li, M, Faser, R, Labar, D. Vagusnerve stimulation treatment for Lennox-Gastaut syndrome. J Child Neurol 2000;15:509512.
117. Hornig, GW, Murphy, JV, Schallert, G, Tilton, C. Left vagus nervestimulation in children with refractory epilepsy an update. SouthMed J 1997;90:484488.

Related content

Powered by UNSILO

The Epileptic Encephalopathies of Infancy and Childhood

  • Elaine Wirrell (a1), Kevin Farrell (a2) and Sharon Whiting (a3)

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.